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Introduction
 Squamous cell carcinoma (SCC) is the most frequent 
malignant tumor in the oral and maxillofacial region, 
and its metastatic and invasive ability results in a poor 
prognosis.  Recent advances in molecular biology have 
revealed that these abilities are assisted by multiple 
proteinases that degrade the extracellular components 
of stromal and vascular tissues1.  Matrix metallopro-
teinases (MMPs) play a particularly important role in 
tumor progression2, and the expression levels of MMPs 
are correlated with cancer invasion and metastasis3.  It 
has been reported that MMP genes are regulated by 
AP-1 and ets-related transcription factors that bind to 
promoter regions of MMPs4–7.
 The Ets transcription factors are large family impli-
cated in the control of cellular proliferation, differentia-
tion and tumorigenesis, and over-expression of various 
Ets proteins can lead to the neoplastic transformation 
of cells in culture and cause tumors in nude mice8. 
Many studies showed that Ets-1 controls the expression 
of a number of genes involved in extracellular matrix 
remodeling and might play a role in cell migration and 
tumor invasion9–11.
 In this study, we investigated the direct inhibitory ef-
fects of Ets-1 caused by transfection with a vector ex-
pressing antisense (AS) Ets-1 mRNA and analyzed AS 
Ets-1 transfected HSC3 cells, comparing them with the 
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Abstract : Ets-1 is an Ets family transcription factor, can up-regulate the transcription of matrix metallopro-
teinase (MMP) genes and confers an invasive phenotype on human cancer cells.  HSC3 is an oral squamous 
cell carcinoma-derived cell line, and it manifests high levels of Ets-1 and MMP-9 gene expression that are as-
sociated with invasive potential.  In this study, we investigated the effect of Ets-1 on the invasive properties of 
oral cancer from a molecular biological perspective.  We constructed an Ets-1 antisense (AS) expression vector, 
transfected HSC3 cells with the vector, and obtained HSC3AS cells that express Ets-1 AS RNA.  The expres-
sion of Ets-1 and MMP-9 was analyzed with RT-PCR.  The invasive ability of the HSC3AS cells was deter-
mined using a matrigel invasion assay and MMP-9 production was measured using gelatin zymography.  The 
amount of Ets-1 mRNA was signiﬁ cantly reduced in HSC3AS cells compared with parental HSC3 cells and 
the control transfected with empty vector.  Matrigel invasion assay revealed that the HSC3AS cells had lower 
invasive ability.  Gelatin zymography demonstrated that HSC3AS MMP-9 productions were decreased com-
pared with those of parental HSC3 cells and the control.  These results imply that transfection of AS Ets-1 in-
hibits oral cancer invasion by down-regulating MMP-9 genes.
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highly invasive parental HSC3 cells, especially with re-
gard to MMP9 expression and invasive ability.
 Materials and Methods
1. Construction of the AS Ets-1 expression vector
 The AS Ets-1 expression vector was constructed as 
follows.  The Ets-1 cDNA was ampliﬁ ed by RT-PCR us-
ing total RNA extracted from the HSC3 cells.  PCR was 
performed to generate ampliﬁ ed fragments including 
the Ets-1 open reading frames.  Nucleotide sequences of 
the primers were : 5'-GTCGGATTCACTCCGGGCAC-
CATGAAGGCGGCCG-3' and 5'-GTCGGATTCCCAT-
CACTCGTCGGCATCTAACTTG-3'.
 Ampliﬁ ed cDNA was digested with BamHI (under 
line) and cloned into pGEM-4Z.  The orientation of the 
inserts was determined by a restriction map and further 
conﬁ rmed by sequencing.  The AS cDNAs corresponding 
to the open reading frame were subcloned into the Bam-
HI site of pSG5 (Stratagene) (Fig. 1).
2. Cell culture and transfection of the AS Ets-1
 The human oral SCC derived cell line HSC3 (JCRB, 
Osaka, Japan) was used for the transfection of an AS 
Ets-1 expression vector.  It was maintained in Dulbec-
co's modiﬁ ed Eagle's medium (DMEM) with 10% fetal 
bovine serum (FBS).
 One microgram each of AS Ets-1 expression vector or 
control pSG5 vector (without the inserted Ets-1 open 
reading frames) was transfected to HSC3 with lipo-
fectamine plus reagentⓇ (Life Technologies, NY, USA) 
according to the manufacturer's protocol.
 After incubation for 24 hours at 37℃, FBS was added 
and cells were incubated.  Experimental groups were di-
vided into 3 groups of AS Ets-1 expression vector, con-
trol pSG5 vector and normal HSC3 cells.  In each group, 
1× 105 cells were cultured and seeded into 35 mm 
dishes.
3. RNA preparation and RT-PCR
 After 48 hours from transfection, total RNA was iso-
lated using TRIZOL ReagentⓇ (Life Technologies, Inc., 
NY, USA) according to the manufacturer's protocol.  Ten 
microliters of reverse transcription buffer (3 mM MgCl2, 
10 mM Tris-HCl, pH 8.3, 75 mM KCl, 1 mM BSA) con-
taining 1 μg of RNA, 0.2 μg oligo-dT primers, 0.5 mM 
dNTP, 5 U of RNasin, and 100 U of MMLV-RT (Bethesda 
Research Laboratories Life Technologies, Inc.) was incu-
bated at 37℃ for 60 min, and a portion of each RT prod-
uct was ampliﬁ ed by PCR.
 Ets-1, MMP9 and β-actin primer sequences were as 
follows : 5'-GATAGCAAAGTAGTCATTCTGC-3' and 
5'-TCAAGTTAATGGAGTCAACCCA-3' for Ets-1 mRNA, 
5'-TGGCAGAAATAGGCTTTCTCT-3' and 5'-GGAAC-
CAGCTGTATTTGTTCA-3' for MMP9 mRNA, and 
5'-GAAAATCTGGCACCACACCTT-3' and 5'-TTGAAGG-
TAGTTTCGTGGAT-3' for β-actin.
 The reactions consisted of 40 cycles of heat denatur-
ation at 94℃ for 1 min, annealing the primers to the 
DNA at 52℃ for 2 min, and chain extension with Taq 
polymerase at 72℃ for 1 min, followed by a ﬁ nal exten-
sion at 72℃ for 20 min.  After ampliﬁ cation, the PCR 
reaction mixture was analyzed by 2% agarose gel elec-
trophoresis and stained with ethidium bromide.
4. Matrigel invasion assay
 The assays were performed according to the manufac-
turer's instructions.  Brieﬂ y, cells (1× 105/well) were 
seeded in a 6-well BioCoat MATRIGEL Invasion Cham-
berⓇ (Becton Dickinson, Bedford, MA, USA) in DMEM 
containing 10% (v/v) heat inactivated fetal calf serum. 
After 48 hours of incubation, the noninvading cells were 
removed from the upper surface of the membrane by 
scrubbing, and the membrane was stained with a Diff-
Quick stain kit.  Subsequently, invading cells were 
counted using a microscope and the invasion index 
(=cells migrating through Matrigel coated membrane/ 
cells migrating through control insert membrane) was 
Fig. 1　Schematic representation of AS Ets-1
The Ets-1 cDNA was ampliﬁ ed by RT-PCR using total RNA 
extracted from the HSC3 cells. PCR was performed to gen-
erate ampliﬁ ed fragments including the Ets-1 open read-
ing frames.
Ampliﬁ ed cDNA was digested with BamHI and cloned into 
pGEM-4Z. The orientation of the inserts was determined 
by a restriction map and further conﬁ rmed by sequencing. 
The AS Ets-1 cDNAs corresponding to the open reading 
frames were subcloned into the BamHI site of pSG5.
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measured.
5. Zymogram
 SDS-substrate polyacrylamide gel electrophoresis 
(SDS-PAGE) was performed with gelatin (0.1%) and 
12% polyacrylamide in the gels.  After incubation in se-
rum-free medium for 48 hours, conditioned medium 
from AS Ets-1, control and normal HSC3 cells were sub-
jected to zymography.  Electrophoresis was carried out 
at 60 mA for 2 hours, and then samples were incubated 
overnight in 0.05 mol/L Tris/HC1 (pH 7.5) buffer con-
taining 10 mol/L CaCl.  Gels were stained with Coo-
massie Blue (0.25%) and destained in methanolacetic 
acid water (50 : 10 : 40).
Results
1. Effect of AS Ets-1 RNA expression on Ets-1 
mRNA
 To determine whether AS Ets-1 reduced the level of 
Ets-1 mRNA, total RNA from AS Ets-1 transfectants 
was analyzed by RT-PCR.  The amount of Ets-1 mRNA 
was signiﬁ cantly reduced in the HSC3AS cells com-
pared with those of the parental HSC3 cells and the 
control (Fig. 2).
2. In vitro invasion activities of AS Ets-1 transfec-
tants
 The invasive activity of transfectants was assayed in 
vitro by a matrigel invasion chamber.  Both parental 
HSC3 cells and control transfectants with the empty 
vector were invasive.  The invasiveness of AS Ets-1 
transfectants was lower compared to the parental cells 
and the control (Fig. 3).
3. Reduction of MMP-9 expression in AS Ets-1 
cells
 We examined the effects of AS Ets-1 on MMP-9 ex-
pression by RT-PCR.  The amount of MMP-9 mRNA was 
signiﬁ cantly reduced in the HSC3AS cells compared 
with those of the parental HSC3 cells and the control 
(Fig. 4).  After incubation in serum-free medium for 24 
hours, conditioned medium from HSC3AS, HSC3 and 
the control cells were subjected to gelatin zymography. 
HSC3AS cells showed less 92-kDa type collagenolytic 
activity than parental HSC3 cells and the control on a 
zymogram (Fig. 5).
Fig. 2　 Effect of AS Ets-1 RNA expression on Ets-1 mRNA 
by RT-PCR
 After 48 hours from transfection, total RNA was 
isolated.
 The reactions consisted of 40 cycles of heat dena-
turation at 94℃ for 1 min, annealing the primers 
to the DNA at 52℃ for 2 min, and chain extension 
with Taq polymerase at 72℃ for 1 min, followed 
by a ﬁ nal extension at 72℃ for 20 min. After am-
pliﬁ cation, the PCR reaction mixture was ana-
lyzed by 2% agarose gel electrophoresis and 
stained with ethidium bromide.
 The amount of Ets-1 mRNA was signiﬁ cantly re-
duced in the HSC3AS cells compared with the pa-
rental HSC3 cells and the control β-actin mRNA 
is an internal marker of applied RNA amounts.
 Lane 1 : HSC3 AS, Lane 2 : control, Lane 3 : HSC3.
Fig. 3　In vitro invasion activity on AS Ets-1 transfec-
tants
 Brieﬂ y, cells (1× 105/well) were seeded in a 6-well 
Bio Coat MATRIGEL Invasion Chamber in 
DMEM containing 10% (v/v) heat inactivated fetal 
calf serum. After 48 hours of incubation, the non-
invading cells were removed from the upper sur-
face of the membrane by scrubbing, and the mem-
brane was stained with a Diff-Quik stain kit. 
Subsequently, invading cells were counted using a 
microscope and the invasion index (= cells migrat-
ing through Matrigel coated membrane/ cells mi-
grating through control insert membrane) was 
measured. The invasiveness of AS transfectants 
was lower compared to the parental HSC3 cells 
and control cells.
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Discussion
 Invasion into surrounding tissues and metastasis to 
distant organs are major characteristics of malignant 
tumor cells.  Various matrix-degrading enzymes are in-
volved in these processes, and MMPs have been shown 
to play a key role in helping cancer cells to invade 
through extracellular matrix and form metastatic le-
sions12.  It has been reported that there is a close rela-
tionship between the level of MMP expression and can-
cer cell malignancy both in vitro13 and in vivo14. 
Especially MMP-1, -3, and -9 are thought to play impor-
tant roles in cancer invasion and metastasis15–19.
 The v-ets oncogene was originally discovered as a 
part of a fusion protein expressed by a transforming ret-
rovirus (avian E26)20,21, and was later shown to be 
transduced from a cellular gene22.  Approximately 30 re-
lated proteins have been found in various species that 
resemble the v-ets protein in the so-called Ets domain. 
The Ets domain has been shown to be a DNA-binding 
domain that speciﬁ cally interacts with sequences con-
taining the common core nucleotide GGAA/T23.  Fur-
thermore, it is involved in protein-protein interactions 
with co-factors that help determine its biological activi-
ty.  Many of the Ets-related proteins have been shown 
to be transcription activators, and it has been revealed 
that the ets-binding sequence is important for the active 
transcription of MMP genes4–6.  The ets-binding se-
quences, as well as a phorbol-ester-responsive element, 
are required for the phorbol-ester- and oncogene-stimu-
lated transcription of MMP-1 and MMP-3 (stromelysin) 
genes4,24.
 In this study, we used HSC3, an invasive oral SCC-
derived cell line, and investigated the inhibitory effects 
of Ets-1 on invasive HSC3 cells after transfection with 
an AS Ets-1 expression vector.
 The signal intensity of endogenous Ets-1 mRNA in AS 
cells was signiﬁ cantly weaker than those of parental 
HSC3 cells and the control transfectant.
 Next, we examined the mRNA and protein levels of 
the extracellular matrix-degrading enzyme MMP-9. 
MMP-9 mRNA levels were reduced in HSC3AS cells, 
which also showed a reduced amount of MMP-9 protein 
compared with the parental HSC3 cells and the control 
transfectant.
 Furthermore, HSC3AS cells showed a decreased ten-
dency to invade Matrigel, whereas HSC3 cells and the 
control transfectant strongly invaded Matrigel.  Matri-
gel is a reconstituted basement membrane matrix, 
which is mainly composed of type IV collagen, laminin 
and heparan sulfate proteoglycans.  This type IV colla-
gen is degraded by type IV collagenase, MMP-2 and 
MMP-9.  Although MMP-9 enzyme activities were in-
hibited, MMP-2 enzyme activities were not changed 
(data not shown).  Moreover, the MMP-9 gene has an 
ets-binding sequence in its promoter region and is regu-
lated by Ets-related proteins4.  These results indicated 
that inhibition of Ets-1 expression caused the down-reg-
ulation of MMP-9, which resulted in the reduced poten-
tial of the malignant phenotype of cancer cells.  Howev-
er, the reduction rate was about 50% of the control, 
which suggests that factors other than MMP-9 also con-
tribute to the invasion of HSC3 AS cells.  We must con-
sider the effect of the inactivation of Ets-1 on cell motili-
ty, proliferation and the synthesis of other proteases 
such as MMP-3, uPA and TIMP to clarify the signiﬁ -
Fig. 4　RT-PCR expression analyses of MMP-9
The amount of MMP-9 mRNA was signiﬁ cantly reduced in 
the HSC3AS cells compared with the parental HSC3 cells 
and control.
Lane 1 : HSC3 AS, Lane 2 : control, Lane 3 : HSC3.
Fig. 5　Gelatin zymography
SDS-PAGE was performed with gelatin (0.1%) and 10% 
polyacrylamide in the gels. After incubation in serum-free 
medium for 48 hours, conditioned medium from AS Ets-1, 
control and normal HSC3 cells were subjected to zymogra-
phy. Electrophoresis was carried out at 60 mA for 2 hours, 
and then samples were incubated overnight in 0.05 mol/L 
Tris/HC1 (pH 7.5) buffer containing 10 mol/L CaCl. Gels 
were stained with Coomassie Blue (0.25%) and destained 
in methanol acetic acid water (50 : 10 : 40). HSC3AS cells 
showed less 92-kd type collagenolytic activity than the pa-
rental HSC3 cells and control.
Lane 1 : HSC3 AS, Lane 2 : control, Lane 3 : HSC3.
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cance of Ets-1 in the progression of oral cancer.  Further 
study on this point is necessary.
 Recently, gene-based therapy targeting genetic abnor-
malities has been attempted for cancer treatment in ad-
dition to conventional methods such as surgical exci-
sion, chemotherapy, and radiation.  A number of 
oncogene targets have been identiﬁ ed, and investigators 
have used AS oligonucleotides25,26 and AS RNA expres-
sion vectors27,28 to study the inhibitory functions of tar-
geting sequences.  The precise mechanism by which AS 
RNA functions has not been clariﬁ ed yet, and there are 
still some problems in applying it clinically.  However, it 
is possible to target speciﬁ c genes to reduce expression 
by AS RNA and interfere with one of the steps in a dra-
matic down-modulation of the invasive potential of tu-
mor cells.  This AS Ets-1 strategy can suppress oral can-
cer invasion by reducing the expression of several MMP 
genes, including at least MMP-9.  Furthermore, this 
strategy is more stable than other methods such as an-
tisense oligodeoxynucleotides (ODN), small interfering 
RNA (siRNA), ribozyme and decoy ODN.  We therefore 
believe that it offers a new avenue for gene therapy de-
velopment as an adjuvant treatment for human oral 
cancer.
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